ANPCY ANGLE plc Sponsored ADRs

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. It develops and commercializes Parsortix cell separation system, which captures and harvests rare circulating tumor cells in cancer patient blood; and Ziplex multiplex analysis system that is used with the ovarian cancer clinical application and others. The company was founded in 2004 and is based in Guildford, the United Kingdom. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:AGL.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$3.49    OTCQX
As of 03/22/2023     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  04/28/2015
Outstanding shares:  26,058,055
Average volume:  0
Market cap:   $90,812,322
Current dividend yield:  0.00%
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%